Zobrazeno 1 - 2
of 2
pro vyhledávání: '"İstemi Taha, Polat"'
Autor:
Hayri Canbaz, Ufuk Oğuz İdiz, Hayriye Cankar Dal, Fatih Kacıroğlu, Seher Taş, Hikmet Can Çubukçu, Attila Bestemir, Murat Gülşen, İstemi Taha Polat, Abubekir Laloğlu, İbrahim Hakkı Tor, Ekrem Akkurt, Utku Ateş, İsmail Reisli, Esin Koç, Ahmet Cağkan İnkaya, Musa Karakükçü, Mustafa Ceylan, İbrahim C. Haznedaroğlu, Haluk Akın
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 4, Pp 222-229 (2022)
Objective: Many methods are used in the treatment of coronavirus disease 2019 (COVID-19), which causes acute respiratory distress syndrome (ARDS), and there are conflicting reports in the literature regarding the results of mesenchymal stem cell (MSC
Externí odkaz:
https://doaj.org/article/917cd3544b814466820c77dd6ad17791
Autor:
Hayri, Canbaz, Ufuk Oğuz, İdiz, Hayriye, Cankar Dal, Fatih, Kaçıroğlu, Seher, Taş, Hikmet Can, Çubukçu, Attila, Beştemir, Murat, Gülşen, İstemi Taha, Polat, Abubekir, Laloğlu, İbrahim Hakkı, Tör, Halik Ekrem, Akkurt, Utku, Ateş, İsmail, Reisli, Esin, Koç, Ahmet Çağkan, İnkaya, Musa, Karakükçü, Mustafa, Ceylan, İbrahim Celalettin, Haznedaroğlu, Haluk, Akın
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 39(4)
Many methods are used in the treatment of coronavirus disease 2019 (COVID-19), which causes acute respiratory distress syndrome (ARDS), and there are conflicting reports in the literature regarding the results of mesenchymal stem cell (MSC) therapy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5ac87b88c30e3aedcc7a1bfe4bfda762
https://pubmed.ncbi.nlm.nih.gov/36250478
https://pubmed.ncbi.nlm.nih.gov/36250478